JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.

JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.

Progressive multifocal leukoencephalopathy (PML) is a frequently fatal disease caused by uncontrolled polyomavirus JC (JCV) in severely immunodeficient patients. We investigated the JCV-specific cellular and humoral immunity in the Swiss HIV Cohort Study. We identified PML cases (n = 29), as well as...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Khanna, N, Wolbers, M, Mueller, N, Garzoni, C, Du Pasquier, R, Fux, C, Vernazza, P, Bernasconi, E, Viscidi, R, Battegay, M, Hirsch, H
Natura:	Journal article
Lingua:	English
Pubblicazione:	2009

Documenti analoghi

JC virus infection of meningeal and choroid plexus cells in patients with progressive multifocal leukoencephalopathy
di: Corbridge, Sarah M., et al.
Pubblicazione: (2021)

JC virus infection of meningeal and choroid plexus cells in patients with progressive multifocal leukoencephalopathy
di: Corbridge, Sarah M., et al.
Pubblicazione: (2022)

Visual loss due to progressive multifocal leukoencephalopathy in a congenital immunodeficiency disorder.
di: Downes, S, et al.
Pubblicazione: (2001)

Progressive multifocal leukoencephalopathy limited to the posterior fossa
di: Rahmat, K., et al.
Pubblicazione: (2010)

Progressive multifocal leukoencephalopathy as the presenting feature of chronic lymphocytic leukaemia.
di: Bruce, DR, et al.
Pubblicazione: (2014)

Progressive multifocal leukoencephalopathy: a retrospective study of 30 cases
di: Adcock, J, et al.
Pubblicazione: (1997)

Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI.
di: Mader, I, et al.
Pubblicazione: (2003)

Progressive multifocal leukoencephalopathy: cidofovir therapy in three patients with underlying hematological disease.
di: Herrlinger, U, et al.
Pubblicazione: (2003)

Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control.
di: Küker, W, et al.
Pubblicazione: (2006)

Human immunodeficiency virus-specific T lymphocyte cell
di: Oxenius, A, et al.
Pubblicazione: (2001)

Chemokine receptor polymorphisms and human immunodeficiency virus disease progression.
di: Easterbrook, P, et al.
Pubblicazione: (1999)

Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection.
di: Edwards, C, et al.
Pubblicazione: (2006)

A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
di: Fagard, C, et al.
Pubblicazione: (2003)

Human Immunodeficiency Virus
di: Gupta, R, et al.
Pubblicazione: (2009)

Human and simian immunodeficiency viruses: virus-receptor interactions.
di: Signoret, N, et al.
Pubblicazione: (1993)

Detection of reactivation and size variation in the regulatory region of JC virus in brain tissue.
di: Mehal, W, et al.
Pubblicazione: (1993)

Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.
di: Aly, L, et al.
Pubblicazione: (2011)

Diabetes, leukoencephalopathy and rage.
di: Toth, C, et al.
Pubblicazione: (2006)

Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression.
di: Frater, A, et al.
Pubblicazione: (2007)

Rancangan Probe untuk Deteksi Virus Jembrana Berdasarkan Region Probe JC2 Gen gag-ca Jembrana Disease Virus
di: Kusumawati, Asmarani, et al.
Pubblicazione: (2015)

THE NIGHTWAY - FARIS,JC
di: Taylor, D
Pubblicazione: (1993)

Human immunodeficiency viruses: neutralization and receptors.
di: Weiss, R, et al.
Pubblicazione: (1988)

Human immunodeficiency virus infection and cancer
di: Newton, R, et al.
Pubblicazione: (1999)

Increased Epstein-Barr virus-specific antibody-levels in HIV-infected individuals developing primary central nervous system lymphoma.
di: Gasser, O, et al.
Pubblicazione: (2007)

Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection.
di: Thobakgale, C, et al.
Pubblicazione: (2009)

The incubation period for human immunodeficiency virus (HIV)
di: Harris, Jeffrey E.
Pubblicazione: (2011)

The role of statistics in human immunodeficiency virus research
di: Anderson, R, et al.
Pubblicazione: (1998)

Seizures in patients with human immunodeficiency virus infection
di: Chadha, D, et al.
Pubblicazione: (2000)

Seizures in patients with human immunodeficiency virus infection.
di: Chadha, D, et al.
Pubblicazione: (2000)

HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection.
di: Duda, A, et al.
Pubblicazione: (2009)

Secretor polymorphism and human immunodeficiency virus infection in Senegalese women.
di: Ali, S, et al.
Pubblicazione: (2000)

Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
di: Auwerx, J, et al.
Pubblicazione: (2004)

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.
di: Török, M, et al.
Pubblicazione: (2011)

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)–associated tuberculous meningitis
di: Török, M, et al.
Pubblicazione: (2011)

Bone mineral density in patients with human immunodeficiency virus infection.
di: Paton, N, et al.
Pubblicazione: (1997)

Aminosugar derivatives as potential anti-human immunodeficiency virus agents.
di: Karpas, A, et al.
Pubblicazione: (1988)

Posterior leukoencephalopathy syndrome associated with amyloid angiopathy
di: Gilo, F, et al.
Pubblicazione: (2010)

[Posterior leukoencephalopathy syndrome associated with amyloid angiopathy].
di: Gilo, F, et al.
Pubblicazione: (2010)

Symptom-based scoring for acute human immunodeficiency virus
di: Sanders, EJ, et al.
Pubblicazione: (2019)

Escape of human immunodeficiency virus from immune control.
di: McMichael, A, et al.
Pubblicazione: (1997)